TherapeuticsMD, Inc. (TXMD) earnings
TXMD earnings moved a median of +0.48% by the close. Quarterly and annual TXMD reports and results, each read against the price at its own news timestamp. Back to the TXMD overview →
25 measured TXMD earnings events.
Where these TXMD earnings landedvs 23 measured TXMD earnings reactions
| Middle 50% of TXMD earnings reactions | -2.29% to +4.21% |
|---|---|
| Median reaction (to close) | +0.48% |
| Measured reactions | 23 |
Point-in-time · zero look-ahead
Half of the 23 TXMD earnings events with a measured close landed between -2.29% and +4.21%; 52% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q TherapeuticsMD, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -0.95% | |
| TherapeuticsMD Announces Second Quarter 2026 Financial Results | Press release | +0.00% | -0.95% | |
| Form 10-Q TherapeuticsMD, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.02% | |
| TherapeuticsMD Announces First Quarter 2026 Financial Results | Press release | +0.00% | +2.02% | |
| Form 10-K/A TherapeuticsMD, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.46% | -2.44% | |
| Form NT 10-K TherapeuticsMD, Inc. For: Dec 31 | SEC filing · Form NT | +1.46% | -2.44% | |
| Form 10-K TherapeuticsMD, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.01% | +6.32% | |
| Form 10-Q TherapeuticsMD, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.35% | — | |
| TherapeuticsMD Announces Third Quarter 2025 Financial Results | Press release | -2.35% | — | |
| Form 10-Q TherapeuticsMD, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +5.46% | |
| TherapeuticsMD Announces Second Quarter 2025 Financial Results | Press release | +0.00% | +5.46% | |
| Form 10-Q TherapeuticsMD, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.07% | -3.31% | |
| TherapeuticsMD Announces First Quarter 2025 Financial Results | Press release | -0.07% | -3.31% | |
| Form 10-K/A TherapeuticsMD, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.60% | +11.20% | |
| Form 10-K TherapeuticsMD, Inc. For: Dec 31 | SEC filing · Form 10-K | +3.92% | -3.73% | |
| Form 10-Q TherapeuticsMD, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.75% | +0.48% | |
| TherapeuticsMD Announces Third Quarter 2024 Financial Results | Press release | +2.75% | +0.48% | |
| Form 10-Q TherapeuticsMD, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.29% | |
| TherapeuticsMD Announces Second Quarter 2024 Financial Results | Press release | +0.00% | -2.29% | |
| Form 10-Q TherapeuticsMD, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.97% | |
| TherapeuticsMD Announces First Quarter 2024 Financial Results | Press release | +0.00% | +2.97% | |
| Form 10-K/A TherapeuticsMD, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.57% | |
| Form 10-K TherapeuticsMD, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.27% | -1.28% | |
| Form 10-Q TherapeuticsMD, Inc. For: Sep 30 | SEC filing · Form 10-Q | +5.47% | +17.41% | |
| TherapeuticsMD Announces Third Quarter 2023 Financial Results | Press release | +5.47% | +17.41% |
Keep exploring
More TXMD: analyst actions → · SEC filings → · TXMD overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| APPLIED BIOSCIENCES CORP (APPB) | 77 | 0.00% | 11% |
| VITALIBIS INC (VCBD) | 76 | 0.00% | 25% |
| Devonian Health Group Inc (GSD_CDNX) | 74 | 0.00% | 0% |
| MAPLE LEAF GREEN WRLD INC (MGWFF) | 74 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.